Metabolic Changes and Therapies in Aging Humans
This scientific article examines the connection between aging and metabolic changes in humans. It focuses on age-related alterations in adipose tissue, muscle, and liver, noting how sedentary habits worsen these effects, while physical activity can help mitigate them. The text also explores potential therapeutic interventions, including caloric restriction, exercise, and novel drug approaches, aimed at maintaining healthy metabolism later in life. The […]
‘Ozempic Teeth’, ‘Tongue’, ‘Breath’ As Possible GLP-1 Med Oral Effects
People have been mouthing off about “Ozempic Teeth”, “Ozempic Tongue” and “Ozempic Breath” on social media. But how much teeth do these claims about GLP-1 agonists have?
FDA Halts Sale of Off-brand Ozempic and Other GLP-1 Meds
Post Content
50% Tariffs on the EU? Or, Wegovy for me, but not for thee?
Macro impact doesn’t seem large according to Yale Budget Lab, but I can hardly wait to see how much a 50% increase in Ozempic and Wegovy prices will go over with the public. Source: FT. There is speculation that Mr. Trump is using one of a a similar GLP-1 agonist medication, but we can’t be […]
Can weight loss drugs help you drink less alcohol?
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.
CI’s Unit Unveils Offering to Expand Access to GLP-1 Medications
The health services arm of The Cigna Group CI, Evernorth, recently introduced a pharmacy benefit offering designed to enhance access to the weight loss medications WEGOVY and ZEPBOUND. This innovative offering addresses critical market demand by providing affordable access to weight loss medications for both patients and health plan sponsors. For patients, the monthly copay […]
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 — Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication, according to a study…
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
FRIDAY, May 23, 2025 — A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
The U.S. Food and Drug Administration (FDA) already declared that…